This program is initiated, funded, and developed by Biogen.
Advertisement
Articles by This program is initiated, funded, and developed by Biogen.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Lumvoa gains US FDA approval for thyroid eye disease with class-first broad label
2
European Dry Eye Society Congress 2026: real-world evidence on Artelac Complete in dry eye disease
3
DEX implant shows benefit across RVO subgroups in real-world retrospective study
4
Q&A: Uveitis risk rises as immune checkpoint inhibitor use expands
5